__NUXT_JSONP__("/drugs/Suramin_Sodium", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"129-46-4",chebiId:"",chemicalFormula:"C51H34N6O23S6.6Na",definition:"A sodium salt form of suramin, a polysulphonated naphthylurea with potential antineoplastic activity.  Suramin blocks the binding of various growth factors, including insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and tumor growth factor-beta (TGF-beta), to their receptors, thereby inhibiting endothelial cell proliferation and migration.  This agent also inhibits vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-induced angiogenesis; retroviral reverse transcriptase; uncoupling of G-proteins from receptors; topoisomerases; cellular folate transport; and steroidogenesis.",fdaUniiCode:"89521262IH",identifier:"C1848",preferredName:b,semanticType:"Organic Chemical",subclassOf:["C1971"],synonyms:["309 F","8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-1,3,5-naphthalenetrisulfonic Acid Hexasodium Salt","Antrypol","Bayer 205","Belganyl","CI-1003","Fourneau 309","Germanin","Metaret","Moranyl","Naganin","Naganinum","Naganol","Naphuride","SURAMIN SODIUM","Sodium Suramin","Sodium suramin","Suramin Hexasodium",b,"Suramin sodium"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FSuramin_Sodium",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Suramin_Sodium","Suramin Sodium","2021-10-30T13:36:53.363Z")));